跳至主要内容
临床试验/ISRCTN29255275
ISRCTN29255275已完成不适用

A randomised controlled trial of continuous subcutaneous insulin infusion (CSII) compared to multiple daily injection (MDI) regimens in children and young people at diagnosis of type I diabetes mellitus (TIDM)

Alder Hey Children's NHS Foundation Trust (UK)0 个研究点目标入组 316 人开始时间: 2010年11月12日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
316

研究概览

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Newly diagnosed TIDM using standard diagnostic practise (WHO Definition 2006)
  • 2. Age 6 months - 15 years (inclusive)
  • 3. Willing to give consent for the study

排除标准

  • 1. Treated previously for diabetes
  • 2. Haemoglobinopathy
  • 3. Co-existing pathology conditions likely to affect glycaemic control, e.g. cystic fibrosis
  • 4. Psychological or psychiatric disorders, e.g. eating disorder
  • 5. Receipt of medication likely to affect glycaemic control, e.g. systemic or high dose topical corticosteroid or growth hormone therapy
  • 6. Allergy to a component of insulin aspart or insulin glargine
  • 7. Patient who have a first degree relative with existing TIDM
  • Patients previously diagnosed with coeliac disease or thyroid dysfunction will be eligible to join the study if they have maintained a gluten-free diet/been maintained in a euthyroid state for 3 months prior to the diagnosis of TIDM.

研究者

发起方
Alder Hey Children's NHS Foundation Trust (UK)

相似试验